| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/05/1994 | EP0618207A1 Substituted pyridopyrimidines as antihypertensives |
| 10/05/1994 | EP0618206A1 Pharmaceutical compounds |
| 10/05/1994 | EP0618201A1 Thiadiazinones and their use in the treatment of cardiovascular or asthmatic conditions |
| 10/05/1994 | EP0618193A1 Nitrogen containing bicyclic derivatives as prolyl-endopeptidase inhibitors |
| 10/05/1994 | EP0617957A1 Oral formulations of ubidecarenone in form of capsules |
| 10/05/1994 | EP0533695B1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY |
| 10/05/1994 | EP0482100B1 Novel vitamin d analogues |
| 10/05/1994 | EP0422178B1 Pyrimidine derivatives |
| 10/05/1994 | CN1093090A Cyclopeptides |
| 10/05/1994 | CN1093087A Serotoninergic ergoline derivatives |
| 10/05/1994 | CN1026112C Preparation of tertiar hydroxyalkylxanthin |
| 10/05/1994 | CN1026108C Novel 5-benzyl substituted-benzimidazo-line-2-thion derivatives and a process for preparing the same |
| 10/04/1994 | US5352708 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 10/04/1994 | US5352694 Pharmaceutical agents |
| 10/04/1994 | US5352692 Inhibitors of thromboxane synthetase |
| 10/04/1994 | US5352687 Substituted phenylacetamides |
| 10/04/1994 | US5352685 Gastrointestinal disorders |
| 10/04/1994 | US5352678 Antiischemic piperazinyl- and piperidinyl-cyclohexanes |
| 10/04/1994 | CA1332239C Tetrazole excitatory amino acid receptor antagonists |
| 10/02/1994 | CA2120302A1 Linear adhesion inhibitors |
| 10/02/1994 | CA2120301A1 Thiadiazinones |
| 10/01/1994 | CA2102142A1 Method of inhibiting oxidants using alkylaryl polyether alcohol polymers |
| 09/29/1994 | WO1994021679A1 Inhibitor of vascular endothelial cell growth factor |
| 09/29/1994 | WO1994021671A1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient |
| 09/29/1994 | WO1994021641A1 Process for production of an imidazole derivative |
| 09/29/1994 | WO1994021639A1 [1,2,4] TRIAZOLO [4,3-a] QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE |
| 09/29/1994 | WO1994021629A1 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 09/29/1994 | WO1994021625A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 09/29/1994 | WO1994021619A1 Naphthalene derivatives |
| 09/29/1994 | WO1994021618A1 Nitric 1,2-benzo-isothiazolyl-3(2h)one-1,1-dioxide esters, preparation method therefor and drugs containing same |
| 09/29/1994 | WO1994021607A1 New heterocyclic compounds, their preparation and their use |
| 09/29/1994 | WO1994021590A1 Phenoxyphenylacetic acid derivatives |
| 09/29/1994 | WO1994021278A1 Potassium channel blocking compounds and their use |
| 09/29/1994 | WO1994021275A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
| 09/29/1994 | WO1994021237A1 System for controlled release of antiarrhythmic agents |
| 09/29/1994 | WO1994021235A1 Enhanced circulation effector composition and method |
| 09/29/1994 | WO1994016094A3 Recombinant anti-vla4 antibody molecules |
| 09/29/1994 | WO1994015958A3 Peptide inhibitors of cell adhesion |
| 09/29/1994 | CA2158545A1 [1,2,4,]triazolo[4,3-a]quinaxoline derivatives, their preparation and use |
| 09/29/1994 | CA2158352A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 09/29/1994 | CA2158051A1 Potassium channel blocking compounds and their use |
| 09/29/1994 | CA2157758A1 Compositions for use in human therapeutics, characterised by the association of a muramyl peptide with a cytokine |
| 09/29/1994 | CA2156741A1 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 09/29/1994 | CA2155842A1 Novel heterocycles, their preparation and their use |
| 09/29/1994 | CA2155573A1 Process for production of an imidazole derivative |
| 09/29/1994 | CA2135921A1 Nitic 1,2-benzo-isothiazolyl-3(2h)one-1, 1-dioxide esters, preparation method therefor and drugs containing same |
| 09/29/1994 | CA2135767A1 System for controlled release of antiarrhythmic agents |
| 09/28/1994 | EP0617035A1 Heterotricyclic substituted phenylcyclohexanecarboxylic acid derivatives |
| 09/28/1994 | EP0617030A1 Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes |
| 09/28/1994 | EP0617027A1 N-Benzylpiperazinderivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/28/1994 | EP0617023A1 Benzimidazole derivatives, their preparation and use |
| 09/28/1994 | EP0617001A1 Phenoxyphenylacetic acid derivatives |
| 09/28/1994 | EP0616536A1 INHIBITING TRANSFORMING GROWTH FACTOR $g(b) TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 09/28/1994 | EP0616532A1 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease |
| 09/28/1994 | CN1092775A Pharmaceuticals |
| 09/28/1994 | CN1092771A Aminomethylene substituted non-aromatic heterocycles |
| 09/28/1994 | CN1092765A Novel tryptamine analogues and process for the preparation and the use thereof |
| 09/28/1994 | CN1092654A Use of hyaluronic acid and forms to prevent arterial restenosis |
| 09/27/1994 | US5350759 Bis-aryl amide antagonists of platelet activating factor |
| 09/27/1994 | US5350757 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties |
| 09/27/1994 | US5350753 Treatment of bacterial infectious diseases and septic shock |
| 09/27/1994 | US5350752 Hypotensive agents |
| 09/27/1994 | US5350751 Substituted imidazoles, pharmaceutical compositions containing these, and the use thereof as antagonists of angiotensin II receptors for the treatment of high blood pressure |
| 09/27/1994 | CA2119669A1 Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives |
| 09/27/1994 | CA1332152C Pharmaceutical composition of dihydropyridine compound |
| 09/25/1994 | CA2119692A1 Substituted pyridopyrimidines as antihypertensives |
| 09/25/1994 | CA2119530A1 Pharmaceutical compounds |
| 09/21/1994 | EP0615971A1 5-(Piperazinylalkyl)-1,5-benzothiazepinones useful as calcium antagonists |
| 09/21/1994 | EP0615970A1 Benzene, pyridine and pyrimidine derivative |
| 09/21/1994 | EP0615755A1 Use of tetrahydropyridine derivatives for the manufacture of cardioprotective medicaments |
| 09/21/1994 | EP0615522A1 Muramyl compounds for treatment of septic shock |
| 09/21/1994 | CN1092423A 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenzÛCDÙindoles for treating motion sickness and vomiting |
| 09/21/1994 | CN1092415A Compounds |
| 09/20/1994 | CA2119051A1 Phenoxyphenylacetic acid derivatives |
| 09/19/1994 | CA2119095A1 Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid derivatives |
| 09/15/1994 | WO1994020532A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 09/15/1994 | WO1994020516A1 New sulfated lyso-ganglioside derivatives |
| 09/15/1994 | WO1994020515A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 09/15/1994 | WO1994020508A1 Phosphonic acid derivatives |
| 09/15/1994 | WO1994020499A1 Benzylimidazopyridine derivatives as angiotensin ii receptor antagonists |
| 09/15/1994 | WO1994020493A1 Method for preparing n-methyl 2-(3-pyridyl) (1r,2r)-2-tetrahydrothiopyrancarbothioamide-1-oxide |
| 09/15/1994 | WO1994020491A1 Benzopyranes as potassium channel openers |
| 09/15/1994 | WO1994020481A1 4-amino-2-(hetero)aryl-butanamides useful as 5-ht1a-antagonists |
| 09/15/1994 | WO1994020478A1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
| 09/15/1994 | WO1994020470A1 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
| 09/15/1994 | WO1994020467A1 New 4-aminopyridines, process for preparing the same and medicaments containing the same |
| 09/15/1994 | WO1994020466A1 Novel 2-phenoxy ethylamine derivatives, their preparation and their therapeutical use |
| 09/15/1994 | WO1994020455A1 Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 09/15/1994 | WO1994020128A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 09/15/1994 | WO1994020111A1 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 09/15/1994 | WO1994020109A1 Use of 2h-1,2,4-benzothiadiazine 3(4h)-one 1,1 dioxide derivatives as non-competitive nmda receptor antagonists |
| 09/15/1994 | WO1994020102A2 Medicament for treating or preventing cerebrovascular diseases |
| 09/15/1994 | WO1994020097A1 Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation |
| 09/15/1994 | WO1994020096A1 Method of employing carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation |
| 09/15/1994 | WO1994020092A1 Calcium antagonist |
| 09/15/1994 | WO1994020085A1 Methods and compositions for inhibition of angiogenesis |
| 09/15/1994 | WO1994020083A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 09/15/1994 | WO1994020062A2 Balanoids as protein kinase c inhibitors |
| 09/15/1994 | WO1994017091A3 Foldback triplex-forming oligonucleotides |
| 09/15/1994 | WO1994011394A3 Peptides with organo-protective activity, process for their preparation and their use in the therapy |